Trade Schwab International Small-Cap Equity ETF - SCHC CFD
What is Schwab International Small-Cap Equity ETF (SCHC)?
The Schwab International Small-Cap Equity ETF is an exchange-traded fund designed to provide exposure to small-cap companies outside the United States. It seeks to track the performance of an index that measures the small-cap segment of the international equity market, excluding U.S. companies. The fund invests in a diversified portfolio of stocks from various countries, representing a range of industries and sectors. It aims to offer investors access to growth opportunities in smaller companies that may have higher growth potential compared to larger, more established firms. The fund is managed with an emphasis on replicating the underlying index through a passive investment approach. This ETF is part of a broader suite of investment products offered by its managing firm, which provides a variety of funds catering to different asset classes and investment strategies. It is commonly used by investors seeking international diversification with a focus on smaller capitalization equities.
Schwab International Small-Cap Equity ETF Stock Price Today: Live Overview
The price today is shaped by current trading patterns, with Schwab U.S. Aggregate Bond ETF at $47.02. The session has seen price movement between $45.67 and $47.11, accompanied by a daily change percentage of -0.8887%.
FAQ: Schwab International Small-Cap Equity ETF (SCHC)
What is the current price of SCHC stock?
The ETF is currently priced at $47.02.
Does SCHC pay dividends?
Dividends are paid by the ETF via cash distributions (if applicable).
Does SCHC have a formal corporate presence or regional headquarters in the UAE?
The ETF does not maintain an official presence in the UAE and is accessed through partners or distributors.
What is SCHC best known for?
It is most famous for providing exposure to international small-cap equities.
What assets are typically shown together with SCHC?
Commonly shown alongside SCHC: Vanguard U.K. Gilt UCITS ETF, AMTEK, Centessa Pharmaceuticals Limited
Latest shares articles



